Paper1744087
The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
Noonan DM and 7 others. J Biol Chem, 1991. Cited by 372 papers, by iCite.
Cite this record
ConductScience Library. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. Papers, record 1744087. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1744087
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
- PubMed
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Adhesion Molecules, Neuronal | Major topic |
| Chondroitin Sulfate Proteoglycans | Major topic |
| Heparan Sulfate | Major topic |
| Laminin | Major topic |
| Proteoglycans | Major topic |
| Receptors, LDL | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Base Sequence | |
| Cloning, Molecular | |
| DNA | |
| Heparan Sulfate Proteoglycans | |
| Mice | |
| Molecular Sequence Data | |
| Protein Conformation | |
| Sequence Homology, Nucleic Acid | |
| Tumor Cells, Cultured |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| EY08098 | NEI NIH HHS | United States | P30EY008098 | PubMed and NIH | NIH RePORTER |
| F32 DE05417-02 | NIDCR NIH HHS | United States | F32DE054170 | PubMed | NIH RePORTER |
| GM 45389 | NIGMS NIH HHS | United States | F01GM045389 | PubMed and NIH | NIH RePORTER |
| F32DE005417 | NIH | NIH RePORTER |
Cited by127
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 372 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42677462 | Neurovascular Signaling in the Perivascular Space: Biophysical Principles and Disruption in Hypertension. | Hypertension | 2026 | https://conductscience.org/library/papers/42677462 | PubMed |
| 42676287 | Heparan Sulfate Proteoglycans: Master Regulators of Cellular Signaling, Tissue Development, and Neural Function. | J Neurosci Res | 2026 | https://conductscience.org/library/papers/42676287 | PubMed |
| 42170108 | Integrative multiomics analysis identifies RARRES2 as a regulator of keloid pathogenesis through STAT3/HSPG2 signaling axis. | iScience | 2026 | https://conductscience.org/library/papers/42170108 | PubMed |
| 41555564 | Perlecan, CollagenXVIII, and Agrin Expression in Normo-, Hypo-, and Aganglionic Segments in Hirschsprung's Disease. | Neurogastroenterol Motil | 2026 | https://conductscience.org/library/papers/41555564 | PubMed |
| 39923120 | Extracellular matrix: Dystroglycan interactions-Roles for the dystrophin-associated glycoprotein complex in skeletal tissue dynamics. | Int J Exp Pathol | 2025 | https://conductscience.org/library/papers/39923120 | PubMed |
| 39684762 | Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684762 | PubMed |
| 39184370 | Proteoglycans of basement membranes: Crucial controllers of angiogenesis, neurogenesis, and autophagy. | Proteoglycan Res | 2024 | https://conductscience.org/library/papers/39184370 | PubMed |
| 38046235 | Exosome Derived from Mesenchymal Stem Cells Alleviates Hypertrophic Scar by Inhibiting the Fibroblasts via TNFSF-13/HSPG2 Signaling Pathway. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/38046235 | PubMed |
| 37779898 | Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37779898 | PubMed |
| 37368474 | Loss of the extracellular matrix protein Perlecan disrupts axonal and synaptic stability during Drosophila development. | Elife | 2023 | https://conductscience.org/library/papers/37368474 | PubMed |
| 36551284 | Gabapentin Disrupts Binding of Perlecan to the α2δ1 Voltage Sensitive Calcium Channel Subunit and Impairs Skeletal Mechanosensation. | Biomolecules | 2022 | https://conductscience.org/library/papers/36551284 | PubMed |
| 35537467 | Genetic Disorders of the Extracellular Matrix: From Cell and Gene Therapy to Future Applications in Regenerative Medicine. | Annu Rev Genomics Hum Genet | 2022 | https://conductscience.org/library/papers/35537467 | PubMed |
| 35433700 | Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35433700 | PubMed |
| 34982945 | Extracellular matrix guidance of autophagy: a mechanism regulating cancer growth. | Open Biol | 2022 | https://conductscience.org/library/papers/34982945 | PubMed |
| 34801534 | Hyperglycemia-induced effects on glycocalyx components in the retina. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/34801534 | PubMed |
| 34671250 | The Unifying Hypothesis of Alzheimer's Disease: Heparan Sulfate Proteoglycans/Glycosaminoglycans Are Key as First Hypothesized Over 30 Years Ago. | Front Aging Neurosci | 2021 | https://conductscience.org/library/papers/34671250 | PubMed |
| 34454085 | Impact of perlecan, a core component of basement membrane, on regeneration of cartilaginous tissues. | Acta Biomater | 2021 | https://conductscience.org/library/papers/34454085 | PubMed |
| 33800241 | Perlecan in Pericellular Mechanosensory Cell-Matrix Communication, Extracellular Matrix Stabilisation and Mechanoregulation of Load-Bearing Connective Tissues. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33800241 | PubMed |
| 33767660 | A Novel Pathogenic HSPG2 Mutation in Schwartz-Jampel Syndrome. | Front Neurol | 2021 | https://conductscience.org/library/papers/33767660 | PubMed |
| 33729517 | Pathogenic alleles in microtubule, secretory granule and extracellular matrix-related genes in familial keratoconus. | Hum Mol Genet | 2021 | https://conductscience.org/library/papers/33729517 | PubMed |
Data10
The data bank entries PubMed's record names. Trial numbers are under Trials.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/1744087
GET https://conductscience.org/api/papers/v1/1744087/cited_by?page=2